Overview

RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
0
Participant gender:
All
Summary
Remimazolam besylate, as a new benzodiazepine drug, has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the safety and effectiveness of remimazolam besylate n the sedation of mechanically ventilated patients after oral and maxillofacial surgery in the ICU
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Treatments:
Midazolam
Propofol
Criteria
Inclusion Criteria:

- Age ≥18 years old

- mechanical ventilation patients with expected ICU stay time <72h

- People who need immediate sedative treatment

Exclusion Criteria:

- pregnancy;

- can not get RASS score from patients

- allergy to drugs